Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Altaire Gel forming solution is an ophthalmic product developed for the treatment of mild to moderate dry eye. Its primary active ingredient, Carboxymethylcellulose Sodium, is a cellulose derivative that functions as an artificial tear, providing lubrication and moisture to the ocular surface. The gel-forming characteristic of the solution is designed to enhance its retention time on the eye, aiming to deliver prolonged relief from symptoms of dryness and irritation. This product is associated with Innovative Medical as a developer and Altaire Pharmaceuticals as a manufacturer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Altaire Gel forming solution.